NCT02873767View on ClinicalTrials.gov

A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

PR1

"* Active substance: UCB4019~* Route of Administration: subcutaneously"

OTHER

PL1

"* Active substance: Placebo~* Concentration: 0.9 % saline~* Route of Administration: subcutaneously"

Trial Locations (1)

Unknown

Up0028 001, London

All Listed Sponsors
lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT02873767 - A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers | Biotech Hunter | Biotech Hunter